TY - JOUR
T1 - Utility of the Repeat and Point Test for Subtyping Patients with Primary Progressive Aphasia
AU - Seckin, Mustafa
AU - Ricard, Ingrid
AU - Raiser, Theresa
AU - Heitkamp, Nari
AU - Ebert, Anne
AU - Prix, Catharina
AU - Levin, Johannes
AU - Diehl-Schmid, Janine
AU - Riedl, Lina
AU - Roßmeier, Carola
AU - Hoen, Nora
AU - Schroeter, Matthias L.
AU - Marschhauser, Anke
AU - Obrig, Hellmuth
AU - Benke, Thomas
AU - Kornhuber, Johannes
AU - Fliessbach, Klaus
AU - Schneider, Anja
AU - Wiltfang, Jens
AU - Jahn, Holger
AU - Fassbender, Klaus
AU - Prudlo, Johannes
AU - Lauer, Martin
AU - Duning, Thomas
AU - Wilke, Carlo
AU - Synofzik, Matthis
AU - Anderl-Straub, Sarah
AU - Semler, Elisa
AU - Lombardi, Jolina
AU - Landwehrmeyer, Bernard
AU - Ludolph, Albert
AU - Otto, Markus
AU - Danek, Adrian
N1 - Publisher Copyright:
© 2022 Lippincott Williams and Wilkins. All rights reserved.
PY - 2022/1/1
Y1 - 2022/1/1
N2 - Background: Primary progressive aphasia (PPA) may present with three distinct clinical sybtypes: semantic variant PPA (svPPA), nonfluent/agrammatic variant PPA (nfvPPA), and logopenic variant PPA (lvPPA). Objective: The aim was to examine the utility of the German version of the Repeat and Point (R&P) Test for subtyping patients with PPA. Method: During the R&P Test, the examiner reads out aloud a noun and the participants are asked to repeat the word and subsequently point to the corresponding picture. Data from 204 patients (68 svPPA, 85 nfvPPA, and 51 lvPPA) and 33 healthy controls were analyzed. Results: Controls completed both tasks with >90% accuracy. Patients with svPPA had high scores in repetition (mean=9.2±1.32) but low scores in pointing (mean=6±2.52). In contrast, patients with nfvPPA and lvPPA performed comparably in both tasks with lower scores in repetition (mean=7.4±2.7 for nfvPPA and 8.2±2.34 for lvPPA) but higher scores in pointing (mean=8.9±1.41 for nfvPPA and 8.6±1.62 for lvPPA). The R&P Test had high accuracy discriminating svPPA from nfvPPA (83% accuracy) and lvPPA (79% accuracy). However, there was low accuracy discriminating nfvPPA from lvPPA (<60%). Conclusion: The R&P Test helps to differentiate svPPA from 2 nonsemantic variants (nfvPPA and lvPPA). However, additional tests are required for the differentiation of nfvPPA and lvPPA.
AB - Background: Primary progressive aphasia (PPA) may present with three distinct clinical sybtypes: semantic variant PPA (svPPA), nonfluent/agrammatic variant PPA (nfvPPA), and logopenic variant PPA (lvPPA). Objective: The aim was to examine the utility of the German version of the Repeat and Point (R&P) Test for subtyping patients with PPA. Method: During the R&P Test, the examiner reads out aloud a noun and the participants are asked to repeat the word and subsequently point to the corresponding picture. Data from 204 patients (68 svPPA, 85 nfvPPA, and 51 lvPPA) and 33 healthy controls were analyzed. Results: Controls completed both tasks with >90% accuracy. Patients with svPPA had high scores in repetition (mean=9.2±1.32) but low scores in pointing (mean=6±2.52). In contrast, patients with nfvPPA and lvPPA performed comparably in both tasks with lower scores in repetition (mean=7.4±2.7 for nfvPPA and 8.2±2.34 for lvPPA) but higher scores in pointing (mean=8.9±1.41 for nfvPPA and 8.6±1.62 for lvPPA). The R&P Test had high accuracy discriminating svPPA from nfvPPA (83% accuracy) and lvPPA (79% accuracy). However, there was low accuracy discriminating nfvPPA from lvPPA (<60%). Conclusion: The R&P Test helps to differentiate svPPA from 2 nonsemantic variants (nfvPPA and lvPPA). However, additional tests are required for the differentiation of nfvPPA and lvPPA.
KW - agrammatism
KW - classification
KW - primary progressive aphasia
KW - repetition
KW - single-word comprehension
UR - http://www.scopus.com/inward/record.url?scp=85123852572&partnerID=8YFLogxK
U2 - 10.1097/WAD.0000000000000482
DO - 10.1097/WAD.0000000000000482
M3 - Article
C2 - 35001030
AN - SCOPUS:85123852572
SN - 0893-0341
VL - 36
SP - 44
EP - 51
JO - Alzheimer Disease and Associated Disorders
JF - Alzheimer Disease and Associated Disorders
IS - 1
ER -